Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Wealthfront Corp | David Fortunato | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.00 per share. | 14 Jul 2025 | 1,620,382 | 1,529,042 | - | 14 | 22,685,348 | Common Stock |
| Liberty Broadband Corp - Ordinary Shares - Series A | John C. Malone | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 1,617,040 | 6,746,933 (4%) | 1% | 0 | Series C Common Stock | |
| Liberty Broadband Corp - Ordinary Shares - Series A | John C. Malone | Director, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Jul 2025 | 1,617,040 | 58,184 | - | 0 | Series B Common Stock | |
| Wealthfront Corp | David Fortunato | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.00 per share. | 14 Jul 2025 | 1,528,003 | 1,621,421 | - | 14 | 21,392,042 | Common Stock |
| GCI Liberty Inc - Ordinary Shares - Series A | John C. Malone | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 14 Jul 2025 | 1,025,978 | 1,025,978 | - | 0 | Series C GCI Group Common Stock | |
| Wealthfront Corp | David Fortunato | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 14.00 per share. | 14 Jul 2025 | 765,154 | 1,481,051 | - | 14 | 10,712,156 | Common Stock |
| Wealthfront Corp | David Fortunato | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 14.00 per share. | 14 Jul 2025 | 765,154 | 1,371,514 | - | 14 | 10,712,156 | Common Stock |
| Wealthfront Corp | David Fortunato | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2025 | 764,625 | 1,983,594 | - | 0 | Common Stock | |
| Wealthfront Corp | David Fortunato | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2025 | 764,625 | 458,775 | - | - | Restricted Stock Units | |
| Wealthfront Corp | David Fortunato | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2025 | 599,200 | 1,218,969 | - | 0 | Common Stock | |
| Wealthfront Corp | David Fortunato | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2025 | 599,200 | 0 | - | - | Restricted Stock Units | |
| Jade Biosciences Inc | Bradford D. Dahms | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 526,000 | 526,000 | - | - | Stock Option (Right to Buy) | |
| Joby Aviation Inc | Paul Sciarra | Director | Sale of securities on an exchange or to another person at price $ 12.38 per share. | 14 Jul 2025 | 500,001 | 57,328,059 | - | 12.4 | 6,190,012 | Common Stock |
| Wealthfront Corp | David Fortunato | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2025 | 475,087 | 2,712,202 | - | 0 | Common Stock | |
| Wealthfront Corp | David Fortunato | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2025 | 475,087 | 791,813 | - | - | Restricted Stock Units | |
| Wealthfront Corp | David Fortunato | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2025 | 383,519 | 619,769 | - | 0 | Common Stock | |
| Wealthfront Corp | David Fortunato | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2025 | 383,519 | 0 | - | - | Restricted Stock Units | |
| Krispy Kreme Inc | Joshua A. Charlesworth | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 350,000 | 350,000 | - | - | Options (Right to Buy) | |
| GCI Liberty Inc - Ordinary Shares - Series A | John C. Malone | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 14 Jul 2025 | 335,044 | 335,044 | - | 0 | Series B GCI Group Common Stock | |
| Krispy Kreme Inc | Raphael Duvivier | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 300,000 | 300,000 | - | - | Options (Right to Buy) | |
| Wealthfront Corp | David Fortunato | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2025 | 253,521 | 2,237,115 | - | 0 | Common Stock | |
| Wealthfront Corp | David Fortunato | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2025 | 253,521 | 0 | - | - | Restricted Stock Units | |
| Krispy Kreme Inc | Nicola J. Steele | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 250,000 | 250,000 | - | - | Options (Right to Buy) | |
| Wealthfront Corp | David Fortunato | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2025 | 242,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Wealthfront Corp | David Fortunato | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.67 per share. | 14 Jul 2025 | 242,000 | 2,083,421 | - | 1.7 | 404,140 | Common Stock |
| GCI Liberty Inc - Ordinary Shares - Series A | John C. Malone | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 14 Jul 2025 | 230,645 | 230,645 | - | 0 | Series A GCI Group Common Stock | |
| Wealthfront Corp | David Fortunato | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2025 | 220,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Wealthfront Corp | David Fortunato | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.45 per share. | 14 Jul 2025 | 220,000 | 1,841,421 | - | 2.5 | 539,000 | Common Stock |
| Planet Labs PBC (Class A) | William Marshall | Director, Co-Founder and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Jul 2025 | 200,000 | 3,460,277 | - | 0 | Class A Common Stock | |
| Krispy Kreme Inc | Atiba D. Adams | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 200,000 | 200,000 | - | - | Options (Right to Buy) | |
| Krispy Kreme Inc | Theresa Zandhuis | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 200,000 | 200,000 | - | - | Options (Right to Buy) | |
| Krispy Kreme Inc | Alison Holder | Chief Brand & Product Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 200,000 | 200,000 | - | - | Options (Right to Buy) | |
| Wealthfront Corp | David Fortunato | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.50 per share. | 14 Jul 2025 | 186,442 | 2,136,668 | - | 1.5 | 279,663 | Common Stock |
| Wealthfront Corp | David Fortunato | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2025 | 186,442 | 0 | - | - | Stock Option (Right to Buy) | |
| Wealthfront Corp | David Fortunato | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.45 per share. | 14 Jul 2025 | 179,184 | 1,708,226 | - | 2.5 | 439,001 | Common Stock |
| Wealthfront Corp | David Fortunato | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2025 | 179,184 | 40,816 | - | - | Stock Option (Right to Buy) | |
| Wealthfront Corp | David Fortunato | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2025 | 176,560 | 2,888,762 | - | 0 | Common Stock | |
| Wealthfront Corp | David Fortunato | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2025 | 176,560 | 0 | - | - | Restricted Stock Units | |
| Krispy Kreme Inc | Joshua A. Charlesworth | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 175,000 | 1,089,686 | - | 0 | Common Stock | |
| Ventas | Robert F. Probst | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 62.22 per share. | 14 Jul 2025 | 168,318 | 336,682 (0%) | 0% | 62.2 | 10,472,746 | Common Stock |
| Ventas | Robert F. Probst | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2025 | 168,318 | 100,773 | - | - | Stock Option (Right to Buy) | |
| Ventas | Robert F. Probst | EVP and CFO | Sale of securities on an exchange or to another person at price $ 65.36 per share. | 14 Jul 2025 | 168,318 | 168,364 (0%) | 0% | 65.4 | 11,000,743 | Common Stock |
| Wealthfront Corp | David Fortunato | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2025 | 162,784 | 23,658 | - | - | Stock Option (Right to Buy) | |
| Wealthfront Corp | David Fortunato | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.50 per share. | 14 Jul 2025 | 162,784 | 2,246,205 | - | 1.5 | 244,176 | Common Stock |
| Krispy Kreme Inc | Raphael Duvivier | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 150,000 | 565,749 | - | 0 | Common Stock | |
| Wealthfront Corp | David Fortunato | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2025 | 143,000 | 0 | - | - | Restricted Stock Units | |
| Wealthfront Corp | David Fortunato | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2025 | 143,000 | 143,000 | - | 0 | Common Stock | |
| Wealthfront Corp | David Fortunato | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2025 | 141,600 | 3,149,424 | - | 0 | Common Stock | |
| Wealthfront Corp | David Fortunato | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2025 | 141,600 | 0 | - | - | Restricted Stock Units | |
| Wealthfront Corp | David Fortunato | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 141,600 | 141,600 | - | - | Restricted Stock Units | |
| Werner Enterprises Inc | Derek J. Leathers | Director, CEO & Chairman | Other type of transaction at price $ 0.00 per share. | 14 Jul 2025 | 130,562 | 387,882 (0%) | 0% | 0 | Common Stock | |
| Krispy Kreme Inc | Nicola J. Steele | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 125,000 | 323,140 | - | 0 | Common Stock | |
| Wealthfront Corp | David Fortunato | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2025 | 119,062 | 3,007,824 | - | 0 | Common Stock | |
| Wealthfront Corp | David Fortunato | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2025 | 119,062 | 833,438 | - | - | Restricted Stock Units | |
| Clearwater Analytics Holdings Inc (Class A) | Sandeep Sahai | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.40 per share. | 14 Jul 2025 | 113,648 | 1,009,311 | - | 4.4 | 500,051 | Class A Common Stock |
| Clearwater Analytics Holdings Inc (Class A) | Sandeep Sahai | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2025 | 113,648 | 761,167 | - | - | Stock Option (Right to Buy) | |
| DocuSign Inc | Allan Thygesen | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 106,015 | 106,015 | - | - | Restricted Stock Units | |
| DocuSign Inc | Allan Thygesen | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 106,015 | 106,015 | - | - | Restricted Stock Units | |
| Dyne Therapeutics Inc | John G. Cox | Director, CEO & President | Purchase of securities on an exchange or from another person at price $ 9.11 per share. | 14 Jul 2025 | 100,000 | 242,179 | - | 9.1 | 911,000 | Common Stock |
| Krispy Kreme Inc | Atiba D. Adams | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 100,000 | 196,934 | - | 0 | Common Stock | |
| Krispy Kreme Inc | Theresa Zandhuis | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 100,000 | 689,330 | - | 0 | Common Stock | |
| Krispy Kreme Inc | Alison Holder | Chief Brand & Product Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 100,000 | 225,794 | - | 0 | Common Stock | |
| Wealthfront Corp | David Fortunato | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2025 | 95,880 | 236,250 | - | 0 | Common Stock | |
| Wealthfront Corp | David Fortunato | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2025 | 95,880 | 0 | - | - | Restricted Stock Units | |
| Wealthfront Corp | David Fortunato | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 14.00 per share. | 14 Jul 2025 | 95,416 | 153,503 | - | 14 | 1,335,824 | Common Stock |
| Wealthfront Corp | David Fortunato | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.00 per share. | 14 Jul 2025 | 91,507 | 61,996 | - | 14 | 1,281,098 | Common Stock |
| Sypris Soln Inc | Jeffrey T. Gill | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 80,000 | 80,000 | - | - | Restricted Stock Units | |
| DocuSign Inc | Allan Thygesen | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 79,511 | 79,511 | - | - | Performance Stock Units | |
| DocuSign Inc | Allan Thygesen | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 79,511 | 79,511 | - | - | Performance Stock Units | |
| GCI Liberty Inc - Ordinary Shares - Series A | Ronald A. Duncan | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 14 Jul 2025 | 79,424 | 79,424 | - | 0 | Series C GCI Group Common Stock | |
| GCI Liberty Inc - Ordinary Shares - Series A | John C. Malone | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 14 Jul 2025 | 71,421 | 71,421 | - | 0 | Series C GCI Group Common Stock | |
| HP Inc. | Manpreet S. Grewal | Global Controller and CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 64,438 | 64,438 | - | - | Restricted Stock Units | |
| Clearwater Analytics Holdings Inc (Class A) | Sandeep Sahai | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.15 per share. | 14 Jul 2025 | 63,648 | 945,663 | - | 22.2 | 1,409,962 | Class A Common Stock |
| Pulse Biosciences Inc | Steven T. Weber | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 55,000 | 55,000 | - | - | Stock Option (right to buy) | |
| Datadog Inc (Class A) | Alexis Le-Quoc | Director, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2025 | 54,000 | 2,617,732 | - | - | Class B Common Stock | |
| Datadog Inc (Class A) | Alexis Le-Quoc | Director, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2025 | 54,000 | 162,000 | - | - | Stock Option (Right to Buy) | |
| DocuSign Inc | Blake Jeffrey Grayson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 51,855 | 51,855 | - | - | Restricted Stock Units | |
| DocuSign Inc | Blake Jeffrey Grayson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 51,855 | 51,855 | - | - | Restricted Stock Units | |
| Clearwater Analytics Holdings Inc (Class A) | Sandeep Sahai | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 22.15 per share. | 14 Jul 2025 | 50,000 | 895,663 | - | 22.2 | 1,107,625 | Class A Common Stock |
| Meridian Holdings Inc | Anthony Brian Goodman | Director, Chief Executive Officer, Ten Percent Owner | 14 Jul 2025 | 50,000 | 8,754,079 | - | 1.7 | 87,000 | Common Stock | |
| Krispy Kreme Inc | Raphael Duvivier | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 46,584 | 415,749 | - | 0 | Common Stock | |
| Ritchie Bros Auctioneers Inc | James Francis Kessler | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 54.83 per share. | 14 Jul 2025 | 45,658 | 153,227 (0%) | 0% | 54.8 | 2,503,428 | Common Shares |
| Ritchie Bros Auctioneers Inc | James Francis Kessler | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2025 | 45,658 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Ritchie Bros Auctioneers Inc | James Francis Kessler | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 110.00 per share. | 14 Jul 2025 | 45,658 | 107,569 (0%) | 0% | 110 | 5,022,380 | Common Shares |
| UiPath Inc (Class A) | Daniel Dines | Director, CEO and Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 12.44 per share. | 14 Jul 2025 | 45,000 | 5,148,376 | - | 12.4 | 559,593 | Class A Common Stock |
| Wealthfront Corp | David Fortunato | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2025 | 45,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Wealthfront Corp | David Fortunato | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.45 per share. | 14 Jul 2025 | 45,000 | 223,919 | - | 2.5 | 110,250 | Common Stock |
| Incyte | Pablo J. Cagnoni | President, R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 43,846 | 43,846 | - | - | Performance Shares | |
| Werner Enterprises Inc | Derek J. Leathers | Director, CEO & Chairman | Other type of transaction at price $ 0.00 per share. | 14 Jul 2025 | 43,392 | 0 (0%) | 0% | 0 | Common Stock | |
| GCI Liberty Inc - Ordinary Shares - Series A | John C. Malone | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 14 Jul 2025 | 42,666 | 42,666 | - | 0 | Series C GCI Group Common Stock | |
| DocuSign Inc | Paula Hansen | Chief Revenue Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 40,331 | 40,331 | - | - | Restricted Stock Units | |
| DocuSign Inc | Paula Hansen | Chief Revenue Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 40,331 | 40,331 | - | - | Restricted Stock Units | |
| DocuSign Inc | Allan Thygesen | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 39,755 | 39,755 | - | - | Performance Stock Units | |
| DocuSign Inc | Allan Thygesen | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 39,755 | 39,755 | - | - | Performance Stock Units | |
| DocuSign Inc | Allan Thygesen | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 39,755 | 39,755 | - | - | Performance Stock Units | |
| DocuSign Inc | Allan Thygesen | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 39,755 | 39,755 | - | - | Performance Stock Units | |
| Incyte | Pablo J. Cagnoni | President, R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 39,471 | 39,471 | - | - | Employee Stock Option (right to buy) | |
| Wealthfront Corp | David Fortunato | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2025 | 35,919 | 0 | - | - | Restricted Stock Units | |
| Wealthfront Corp | David Fortunato | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2025 | 35,919 | 178,919 | - | 0 | Common Stock | |
| A10 Networks Inc | Sheen George Khoury | Executive VP, Sales and Mktg | 14 Jul 2025 | 35,000 | 36,523 (0%) | 0% | 0 | Common Stock | ||
| A10 Networks Inc | Sheen George Khoury | Executive VP, Sales and Mktg | 14 Jul 2025 | 35,000 | 35,000 | - | - | Performance-based Restricted Stock Units | ||
| Pitney Bowes Inc | Deborah Pfeiffer | EVP & Pres, Presort Services | Sale of securities on an exchange or to another person at price $ 12.14 per share. | 14 Jul 2025 | 35,000 | 115,405 (0%) | 0% | 12.1 | 425,037 | Common Stock |
| Sypris Soln Inc | Rebecca R. Eckert | VP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 35,000 | 35,000 | - | - | Restricted Stock Units | |
| Sypris Soln Inc | Curtis S. Petrie | VP of Administration | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 35,000 | 35,000 | - | - | Restricted Stock Units | |
| DocuSign Inc | James P. Shaughnessy | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 34,570 | 34,570 | - | - | Restricted Stock Units | |
| DocuSign Inc | Robert Chatwani | President General Mgr, Growth | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 34,570 | 34,570 | - | - | Restricted Stock Units | |
| DocuSign Inc | James P. Shaughnessy | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 34,570 | 34,570 | - | - | Restricted Stock Units | |
| DocuSign Inc | Robert Chatwani | President General Mgr, Growth | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 34,570 | 34,570 | - | - | Restricted Stock Units | |
| Shattuck Labs Inc | Neil Gibson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 33,150 | 33,150 | - | - | Stock Option (Right to Buy) | |
| Shattuck Labs Inc | Clay B. Siegall | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 33,150 | 33,150 | - | - | Stock Option (Right to Buy) | |
| Shattuck Labs Inc | George S. Golumbeski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 33,150 | 33,150 | - | - | Stock Option (Right to Buy) | |
| Shattuck Labs Inc | Helen M. Boudreau | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 33,150 | 33,150 | - | - | Stock Option (Right to Buy) | |
| Shattuck Labs Inc | Tyler Brous | Director | 14 Jul 2025 | 33,150 | 33,150 | - | - | Stock Option (Right to Buy) | ||
| Shattuck Labs Inc | Carrie Brownstein | Director | 14 Jul 2025 | 33,150 | 33,150 | - | - | Stock Option (Right to Buy) | ||
| Shattuck Labs Inc | Amy Kate Sasser | Director | 14 Jul 2025 | 33,150 | 33,150 | - | - | Stock Option (Right to Buy) | ||
| Shattuck Labs Inc | Michael Lee | Director | 14 Jul 2025 | 33,150 | 33,150 | - | - | Stock Option (Right to Buy) | ||
| Werner Enterprises Inc | Derek J. Leathers | Director, CEO & Chairman | Other type of transaction at price $ 0.00 per share. | 14 Jul 2025 | 32,700 | 49,040 (0%) | 0% | 0 | Common Stock | |
| Werner Enterprises Inc | Derek J. Leathers | Director, CEO & Chairman | Other type of transaction at price $ 0.00 per share. | 14 Jul 2025 | 31,195 | 54,379 (0%) | 0% | 0 | Common Stock | |
| Datadog Inc (Class A) | Alexis Le-Quoc | Director, Chief Technology Officer | 14 Jul 2025 | 30,780 | 483,549 (0%) | 0% | 0.9 | 27,985 | Class A Common Stock | |
| Datadog Inc (Class A) | Alexis Le-Quoc | Director, Chief Technology Officer | 14 Jul 2025 | 30,780 | 2,586,952 | - | - | Class B Common Stock | ||
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 30,692 | 30,692 | - | - | Performance Shares | |
| Alignment Healthcare Inc | Dawn Maroney | President | Sale of securities on an exchange or to another person at price $ 13.44 per share. | 14 Jul 2025 | 30,000 | 2,042,899 | - | 13.4 | 403,347 | Common Stock |
| Sypris Soln Inc | Richard L. Davis | SVP and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 30,000 | 30,000 | - | - | Restricted Stock Units | |
| Incyte | Christiana Stamoulis | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 27,769 | 27,769 | - | - | Performance Shares | |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 27,629 | 27,629 | - | - | Employee Stock Option (right to buy) | |
| Zoom Video Comm Inc (Class A) | Eric S. Yuan | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 74.86 per share. | 14 Jul 2025 | 27,477 | 0 (0%) | 0% | 74.9 | 2,056,882 | Class A Common Stock |
| Bausch Health Companies Inc | Steven H. Lee | SVP, Controller & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 27,371 | 27,371 (0%) | 0% | 0 | Common Shares, No Par Value | |
| DocuSign Inc | Blake Jeffrey Grayson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 25,927 | 25,927 | - | - | Performance Stock Units | |
| DocuSign Inc | Blake Jeffrey Grayson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 25,927 | 25,927 | - | - | Performance Stock Units | |
| Credo Tech Grp Holding Ltd | Chi Fung Cheng | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 99.19 per share. | 14 Jul 2025 | 25,753 | 7,277,903 | - | 99.2 | 2,554,561 | Ordinary Shares |
| Blend Labs Inc (Class A) | Brian Kneafsey | Head of Revenue | 14 Jul 2025 | 25,000 | 721,598 | - | 3.6 | 90,830 | Class A Common Stock | |
| Wealthfront Corp | David Fortunato | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2025 | 25,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Wealthfront Corp | David Fortunato | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.67 per share. | 14 Jul 2025 | 25,000 | 248,919 | - | 2.7 | 66,750 | Common Stock |
| Incyte | Christiana Stamoulis | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 24,998 | 24,998 | - | - | Employee Stock Option (right to buy) | |
| GCI Liberty Inc - Ordinary Shares - Series A | John C. Malone | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 14 Jul 2025 | 24,529 | 24,529 | - | 0 | Series B GCI Group Common Stock | |
| Werner Enterprises Inc | Derek J. Leathers | Director, CEO & Chairman | Other type of transaction at price $ 0.00 per share. | 14 Jul 2025 | 23,275 | 6,019 (0%) | 0% | 0 | Common Stock | |
| Paychex | Martin Mucci | Director, Chairman | Gift of securities by or to the insider at price $ 143.89 per share. | 14 Jul 2025 | 21,642 | 425,275 (0%) | 0% | 143.9 | 3,114,067 | Common Stock |
| Direct Digital Holdings Inc (Class A) | Mark D. Walker | Director, Chairman and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.55 per share. | 14 Jul 2025 | 21,154 | 143,846 | - | 0.6 | 11,635 | Class A Common Stock, par value $0.001 per share |
| DocuSign Inc | Paula Hansen | Chief Revenue Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 20,165 | 20,165 | - | - | Performance Stock Units | |
| DocuSign Inc | Paula Hansen | Chief Revenue Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 20,165 | 20,165 | - | - | Performance Stock Units | |
| Blend Labs Inc (Class A) | Brian Kneafsey | Head of Revenue | 14 Jul 2025 | 20,000 | 746,598 | - | 3.4 | 68,438 | Class A Common Stock | |
| Disc Medicine Inc | Nadim Ahmed | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| Kiniksa Pharma Ltd (Class A) | Eben Tessari | CHIEF OPERATING OFFICER | 14 Jul 2025 | 18,900 | 49,163 (0%) | 0% | 28.7 | 542,808 | Class A Ordinary Share | |
| Johnson Controls | Christopher M. Scalia | EVP and CHRO | Grant, award, or other acquisition of securities at price $ 106.26 per share. | 14 Jul 2025 | 18,821 | 18,856 (0%) | 0% | 106.3 | 1,999,919 | Ordinary Shares |
| Datadog Inc (Class A) | Alexis Le-Quoc | Director, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2025 | 18,750 | 2,605,702 | - | - | Class B Common Stock | |
| Datadog Inc (Class A) | Alexis Le-Quoc | Director, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2025 | 18,750 | 506,250 | - | - | Stock Option (Right to Buy) | |
| Netsol Tech Inc | Naeem Ghauri | President | Purchase of securities on an exchange or from another person at price $ 3.85 per share. | 14 Jul 2025 | 18,279 | 459,853 (3%) | 0% | 3.8 | 70,374 | Common Stock |
| Incyte | Pablo J. Cagnoni | President, R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 17,538 | 234,800 (0%) | 0% | 0 | Common Stock | |
| DocuSign Inc | James P. Shaughnessy | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 17,285 | 17,285 | - | - | Performance Stock Units | |
| DocuSign Inc | Robert Chatwani | President General Mgr, Growth | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 17,285 | 17,285 | - | - | Performance Stock Units | |
| DocuSign Inc | James P. Shaughnessy | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 17,285 | 17,285 | - | - | Performance Stock Units | |
| DocuSign Inc | Robert Chatwani | President General Mgr, Growth | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 17,285 | 17,285 | - | - | Performance Stock Units | |
| Frontdoor Inc | Balakrishnan A. Ganesh | SVP & Chief Technology Officer | 14 Jul 2025 | 17,238 | 17,238 | - | - | Restricted Stock Units | ||
| Hagerty Inc (Class A) | Robert I. Kauffman | Director | Sale of securities on an exchange or to another person at price $ 10.03 per share. | 14 Jul 2025 | 16,972 | 3,459,085 | - | 10.0 | 170,229 | Class A Common Stock |
| Monopar Therapeutics Inc | Christopher M. Starr | Director | 14 Jul 2025 | 16,800 | 21,973 (0%) | 0% | 0.0 | 84 | Common Stock | |
| Monopar Therapeutics Inc | Christopher M. Starr | Director | 14 Jul 2025 | 16,800 | 0 | - | - | Stock Options | ||
| Monopar Therapeutics Inc | Christopher M. Starr | Director | Sale of securities on an exchange or to another person at price $ 40.00 per share. | 14 Jul 2025 | 16,800 | 5,173 (0%) | 0% | 40.0 | 672,020 | Common Stock |
| Monopar Therapeutics Inc | Chandler D. Robinson | Director, Chief Executive Officer | 14 Jul 2025 | 16,800 | 0 | - | - | Stock Options | ||
| Monopar Therapeutics Inc | Chandler D. Robinson | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 40.00 per share. | 14 Jul 2025 | 16,800 | 73,472 (0%) | 0% | 40.0 | 672,020 | Common Stock |
| Monopar Therapeutics Inc | Chandler D. Robinson | Director, Chief Executive Officer | 14 Jul 2025 | 16,800 | 90,272 (0%) | 0% | 0.0 | 84 | Common Stock | |
| Incyte | Paula J. Swain | EVP, Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 16,077 | 16,077 | - | - | Performance Shares | |
| Incyte | Vijay K. Iyengar | EVP, GMAPPS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 16,077 | 16,077 | - | - | Performance Shares | |
| Sypris Soln Inc | Anthony C. Allen | VP and Assistant Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 15,000 | 15,000 | - | - | Restricted Stock Units | |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 68.47 per share. | 14 Jul 2025 | 14,952 | 97,466 (0%) | 0% | 68.5 | 1,023,763 | Common Stock |
| GCI Liberty Inc - Ordinary Shares - Series A | Ronald A. Duncan | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 14 Jul 2025 | 14,870 | 14,870 | - | 0 | Series C GCI Group Common Stock | |
| Hagerty Inc (Class A) | Robert I. Kauffman | Director | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 14 Jul 2025 | 14,862 | 3,476,057 | - | 10 | 148,620 | Class A Common Stock |
| Ventas | Debra A. Cafaro | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 65.45 per share. | 14 Jul 2025 | 14,753 | 1,160,448 (0%) | 0% | 65.5 | 965,584 | Common Stock |
| Ventas | Debra A. Cafaro | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2025 | 14,753 | 707,822 | - | - | Stock Option (Right to Buy) | |
| Ventas | Debra A. Cafaro | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 65.60 per share. | 14 Jul 2025 | 14,753 | 1,145,695 (0%) | 0% | 65.6 | 967,822 | Common Stock |
| Datadog Inc (Class A) | Alexis Le-Quoc | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 139.88 per share. | 14 Jul 2025 | 14,700 | 459,869 (0%) | 0% | 139.9 | 2,056,285 | Class A Common Stock |
| Datadog Inc (Class A) | Alexis Le-Quoc | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 138.75 per share. | 14 Jul 2025 | 14,668 | 474,569 (0%) | 0% | 138.7 | 2,035,122 | Class A Common Stock |
| Incyte | Paula J. Swain | EVP, Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 14,472 | 14,472 | - | - | Employee Stock Option (right to buy) | |
| Incyte | Vijay K. Iyengar | EVP, GMAPPS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 14,472 | 14,472 | - | - | Employee Stock Option (right to buy) | |
| Maplebear Inc | Fidji Simo | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 47.86 per share. | 14 Jul 2025 | 14,233 | 2,032,005 | - | 47.9 | 681,147 | Common Stock |
| Credo Tech Grp Holding Ltd | Chi Fung Cheng | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 98.44 per share. | 14 Jul 2025 | 13,736 | 7,303,656 | - | 98.4 | 1,352,180 | Ordinary Shares |
| Krystal Biotech Inc | Krish S. Krishnan | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 150.30 per share. | 14 Jul 2025 | 13,400 | 1,512,529 (8%) | 0% | 150.3 | 2,014,015 | Common Stock |
| Krystal Biotech Inc | Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 150.30 per share. | 14 Jul 2025 | 13,400 | 1,512,529 (8%) | 0% | 150.3 | 2,014,015 | Common Stock |
| Krystal Biotech Inc | Krish S. Krishnan | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 150.29 per share. | 14 Jul 2025 | 13,335 | 1,443,376 (8%) | 0% | 150.3 | 2,004,125 | Common Stock |
| Krystal Biotech Inc | Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 150.29 per share. | 14 Jul 2025 | 13,335 | 1,443,376 (8%) | 0% | 150.3 | 2,004,125 | Common Stock |
| DocuSign Inc | Blake Jeffrey Grayson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 12,963 | 12,963 | - | - | Performance Stock Units | |
| DocuSign Inc | Blake Jeffrey Grayson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 12,963 | 12,963 | - | - | Performance Stock Units | |
| DocuSign Inc | Blake Jeffrey Grayson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 12,963 | 12,963 | - | - | Performance Stock Units | |
| DocuSign Inc | Blake Jeffrey Grayson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 12,963 | 12,963 | - | - | Performance Stock Units | |
| Chefs` Warehouse Inc | Timothy McCauley | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 65.01 per share. | 14 Jul 2025 | 12,500 | 57,050 (0%) | 0% | 65.0 | 812,625 | Common Stock |
| Oshkosh Corp | Stephen Craig Nordlund | Exec. VP & Pres., Transport | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 12,452 | 12,452 | - | - | Restricted Stock Units | |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 12,277 | 106,592 (0%) | 0% | 0 | Common Stock | |
| Hims & Hers Health Inc (Class A) | Oluyemi Okupe | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 47.70 per share. | 14 Jul 2025 | 11,581 | 54,084 | - | 47.7 | 552,418 | Class A Common Stock |
| GCI Liberty Inc - Ordinary Shares - Series A | John C. Malone | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 14 Jul 2025 | 11,528 | 11,528 | - | 0 | Series B GCI Group Common Stock | |
| Mineralys Therapeutics Inc | David Rodman | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 14.59 per share. | 14 Jul 2025 | 11,366 | 97,907 | - | 14.6 | 165,879 | Common Stock |
| Incyte | Christiana Stamoulis | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 11,107 | 125,759 (0%) | 0% | 0 | Common Stock | |
| Microstrategy Inc (Class A) | W. Ming Shao | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2025 | 10,900 | 139,100 | - | - | Employee Stock Option (Right to buy) | |
| Microstrategy Inc (Class A) | W. Ming Shao | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 40.46 per share. | 14 Jul 2025 | 10,900 | 23,626 (0%) | 0% | 40.5 | 441,014 | Class A Common Stock |
| Datadog Inc (Class A) | Alexis Le-Quoc | Director, Chief Technology Officer | 14 Jul 2025 | 10,688 | 2,595,014 | - | - | Class B Common Stock | ||
| Datadog Inc (Class A) | Alexis Le-Quoc | Director, Chief Technology Officer | 14 Jul 2025 | 10,688 | 494,237 (0%) | 0% | 10.7 | 114,789 | Class A Common Stock | |
| Honeywell | James Masso | Pres & CEO, Process Solutions | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 10,562 | 10,562 | - | - | Restricted Stock Units | |
| DocuSign Inc | Paula Hansen | Chief Revenue Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 10,082 | 10,082 | - | - | Performance Stock Units | |
| DocuSign Inc | Paula Hansen | Chief Revenue Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 10,082 | 10,082 | - | - | Performance Stock Units | |
| DocuSign Inc | Paula Hansen | Chief Revenue Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 10,082 | 10,082 | - | - | Performance Stock Units | |
| DocuSign Inc | Paula Hansen | Chief Revenue Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 10,082 | 10,082 | - | - | Performance Stock Units | |
| Dyne Therapeutics Inc | John G. Cox | Director, CEO & President | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Jul 2025 | 10,000 | 202,179 | - | 0 | Common Stock | |
| Dyne Therapeutics Inc | John G. Cox | Director, CEO & President | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Jul 2025 | 10,000 | 212,179 | - | 0 | Common Stock | |
| Dyne Therapeutics Inc | John G. Cox | Director, CEO & President | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Jul 2025 | 10,000 | 222,179 | - | 0 | Common Stock | |
| Dyne Therapeutics Inc | John G. Cox | Director, CEO & President | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Jul 2025 | 10,000 | 232,179 | - | 0 | Common Stock | |
| Western Asset High Income Opportunity Fund Inc | Peter Daniel Charles Mason | Director | Purchase of securities on an exchange or from another person at price $ 4.02 per share. | 14 Jul 2025 | 10,000 | 10,000 (0%) | 0% | 4.0 | 40,183 | Common Stock |
| Zoom Video Comm Inc (Class A) | Aparna Bawa | Chief Operating Officer | 14 Jul 2025 | 9,836 | 2,670 (0%) | 0% | 74.8 | 735,431 | Class A Common Stock | |
| Honeywell | James Masso | Pres & CEO, Process Solutions | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 9,206 | 9,206 | - | - | Employee Stock Options (right to buy) | |
| Envista Holdings Corp | J. Andrew Pierce | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 9,155 | 9,155 (0%) | 0% | 0 | Common Stock | |
| Monopar Therapeutics Inc | Kim R. Tsuchimoto | Director | 14 Jul 2025 | 8,904 | 20,390 (0%) | 0% | 0.0 | 45 | Common Stock | |
| Monopar Therapeutics Inc | Kim R. Tsuchimoto | Director | Sale of securities on an exchange or to another person at price $ 40.00 per share. | 14 Jul 2025 | 8,904 | 11,486 (0%) | 0% | 40.0 | 356,171 | Common Stock |
| DocuSign Inc | James P. Shaughnessy | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 8,642 | 8,642 | - | - | Performance Stock Units | |
| DocuSign Inc | James P. Shaughnessy | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 8,642 | 8,642 | - | - | Performance Stock Units | |
| DocuSign Inc | Robert Chatwani | President General Mgr, Growth | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 8,642 | 8,642 | - | - | Performance Stock Units | |
| DocuSign Inc | Robert Chatwani | President General Mgr, Growth | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 8,642 | 8,642 | - | - | Performance Stock Units | |
| DocuSign Inc | James P. Shaughnessy | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 8,642 | 8,642 | - | - | Performance Stock Units | |
| DocuSign Inc | James P. Shaughnessy | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 8,642 | 8,642 | - | - | Performance Stock Units | |
| DocuSign Inc | Robert Chatwani | President General Mgr, Growth | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 8,642 | 8,642 | - | - | Performance Stock Units | |
| DocuSign Inc | Robert Chatwani | President General Mgr, Growth | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 8,642 | 8,642 | - | - | Performance Stock Units | |
| Frontdoor Inc | Balakrishnan A. Ganesh | SVP & Chief Technology Officer | 14 Jul 2025 | 8,619 | 8,619 | - | - | Restricted Stock Units | ||
| Hagerty Inc (Class A) | Robert I. Kauffman | Director | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 14 Jul 2025 | 8,362 | 3,490,919 | - | 10 | 83,620 | Class A Common Stock |
| Direct Digital Holdings Inc (Class A) | Mark D. Walker | Director, Chairman and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.54 per share. | 14 Jul 2025 | 8,066 | 135,780 | - | 0.5 | 4,356 | Class A Common Stock, par value $0.001 per share |
| Life360 Inc | Charles Prober | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2025 | 7,930 | 126,880 | - | - | Stock Option (right to buy) | |
| Life360 Inc | Charles Prober | Director | Sale of securities on an exchange or to another person at price $ 64.41 per share. | 14 Jul 2025 | 7,930 | 105,456 | - | 64.4 | 510,771 | Common stock |
| Life360 Inc | Charles Prober | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.18 per share. | 14 Jul 2025 | 7,930 | 113,386 | - | 11.2 | 88,657 | Common stock |
| Hims & Hers Health Inc (Class A) | Oluyemi Okupe | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.01 per share. | 14 Jul 2025 | 7,587 | 65,665 | - | 5.0 | 38,011 | Class A Common Stock |
| Hims & Hers Health Inc (Class A) | Oluyemi Okupe | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2025 | 7,587 | 372,946 | - | - | Stock Option (right to buy) | |
| First Northwest Bancorp | Geraldine L. Bullard | Interim CEO | Grant, award, or other acquisition of securities at price $ 8.30 per share. | 14 Jul 2025 | 7,500 | 35,851 (0%) | 0% | 8.3 | 62,250 | Common Stock |
| Park Aerospace Corp | Carl W. Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.71 per share. | 14 Jul 2025 | 7,500 | 8,500 (0%) | 0% | 8.7 | 65,325 | Common Stock |
| Park Aerospace Corp | Carl W. Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2025 | 7,500 | 0 | - | - | Right to buy option | |
| Ritchie Bros Auctioneers Inc | Darren Watt | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2025 | 7,400 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Ritchie Bros Auctioneers Inc | Darren Watt | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 32.16 per share. | 14 Jul 2025 | 7,400 | 32,274 (0%) | 0% | 32.2 | 237,984 | Common Shares |
| Ritchie Bros Auctioneers Inc | Darren Watt | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 110.00 per share. | 14 Jul 2025 | 7,400 | 24,874 (0%) | 0% | 110 | 814,000 | Common Shares |
| Enovix Corp | Ajay Marathe | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.65 per share. | 14 Jul 2025 | 7,338 | 1,165,843 | - | 14.7 | 107,502 | Common Stock |
| Datadog Inc (Class A) | Alexis Le-Quoc | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 140.58 per share. | 14 Jul 2025 | 7,100 | 452,769 (0%) | 0% | 140.6 | 998,116 | Class A Common Stock |
| Shimmick Corp | Mitchell B. Goldsteen | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.02 per share. | 14 Jul 2025 | 7,000 | 21,324,580 | - | 2.0 | 14,140 | Common Stock, par value $0.01 per share |
| Costco Wholesale | Jeffrey S. Raikes | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Jul 2025 | 6,573 | 20,241 (0%) | 0% | 0 | Common Stock | |
| CalciMedica Inc | Eric W. Roberts | Director, CHIEF BUSINESS OFFICER, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.43 per share. | 14 Jul 2025 | 6,500 | 44,323 | - | 2.4 | 15,810 | Common Stock |
| Qualys Inc | Sumedh S. Thakar | Director, CEO & PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2025 | 6,500 | 32,500 | - | - | Stock Option (right to buy) | |
| Qualys Inc | Sumedh S. Thakar | Director, CEO & PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.56 per share. | 14 Jul 2025 | 6,500 | 224,462 (0%) | 0% | 25.6 | 166,140 | Common Stock |
| Kiniksa Pharma Ltd (Class A) | Eben Tessari | CHIEF OPERATING OFFICER | 14 Jul 2025 | 6,500 | 68,063 (0%) | 0% | 8.8 | 57,395 | Class A Ordinary Share | |
| Kiniksa Pharma Ltd (Class A) | Eben Tessari | CHIEF OPERATING OFFICER | 14 Jul 2025 | 6,500 | 32,000 | - | - | Share Option | ||
| Credo Tech Grp Holding Ltd | Chi Fung Cheng | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 97.42 per share. | 14 Jul 2025 | 6,469 | 7,317,392 | - | 97.4 | 630,182 | Ordinary Shares |
| Incyte | Paula J. Swain | EVP, Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 6,430 | 106,482 (0%) | 0% | 0 | Common Stock | |
| Incyte | Vijay K. Iyengar | EVP, GMAPPS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 6,430 | 41,523 (0%) | 0% | 0 | Common Stock | |
| Mineralys Therapeutics Inc | David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2025 | 6,349 | 88,880 | - | - | Stock Option | |
| Mineralys Therapeutics Inc | David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.08 per share. | 14 Jul 2025 | 6,349 | 109,273 | - | 1.1 | 6,857 | Common Stock |
| Zoom Video Comm Inc (Class A) | Eric S. Yuan | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 74.49 per share. | 14 Jul 2025 | 6,214 | 27,477 (0%) | 0% | 74.5 | 462,851 | Class A Common Stock |
| Perma-Fix Environmental Services Inc | Richard Grondin | EVP of Hanford & Int. Waste Op | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2025 | 6,000 | 18,000 | - | - | Stock Option | |
| Perma-Fix Environmental Services Inc | Richard Grondin | EVP of Hanford & Int. Waste Op | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.95 per share. | 14 Jul 2025 | 6,000 | 36,686 (0%) | 0% | 4.0 | 23,700 | Common Stock |
| Intellicheck Inc | Guy L. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 5,714 | 5,714 | - | - | Restricted Stock Units (RSUs) | |
| GCI Liberty Inc - Ordinary Shares - Series A | Ronald A. Duncan | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 14 Jul 2025 | 5,431 | 5,431 | - | 0 | Series C GCI Group Common Stock | |
| Theravance Biopharma Inc | Rhonda Farnum | SVP, COMM & MEDICAL AFFAIRS | Sale of securities on an exchange or to another person at price $ 11.39 per share. | 14 Jul 2025 | 5,318 | 330,918 (0%) | 0% | 11.4 | 60,548 | Ordinary Shares |
| GCI Liberty Inc - Ordinary Shares - Series A | John C. Malone | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 14 Jul 2025 | 5,088 | 5,088 | - | 0 | Series A GCI Group Common Stock | |
| Gilead Sciences | Jeffrey A. Bluestone | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 67.45 per share. | 14 Jul 2025 | 5,000 | 13,920 (0%) | 0% | 67.5 | 337,250 | Common Stock |
| Gilead Sciences | Jeffrey A. Bluestone | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2025 | 5,000 | 9,665 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Gilead Sciences | Jeffrey A. Bluestone | Director | Sale of securities on an exchange or to another person at price $ 109.74 per share. | 14 Jul 2025 | 5,000 | 8,920 (0%) | 0% | 109.7 | 548,700 | Common Stock |
| Perma-Fix Environmental Services Inc | Richard Grondin | EVP of Hanford & Int. Waste Op | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2025 | 5,000 | 10,000 | - | - | Stock Option | |
| Perma-Fix Environmental Services Inc | Richard Grondin | EVP of Hanford & Int. Waste Op | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.00 per share. | 14 Jul 2025 | 5,000 | 33,780 (0%) | 0% | 7.0 | 35,025 | Common Stock |
| Chefs` Warehouse Inc | Timothy McCauley | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 65.21 per share. | 14 Jul 2025 | 5,000 | 52,050 (0%) | 0% | 65.2 | 326,050 | Common Stock |
| Cytokinetics Inc | Robert I. Blum | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 38.15 per share. | 14 Jul 2025 | 5,000 | 393,108 (0%) | 0% | 38.2 | 190,750 | Common Stock |
| Sprout Social Inc (Class A) | Karen Walker | Director | Sale of securities on an exchange or to another person at price $ 19.04 per share. | 14 Jul 2025 | 5,000 | 28,963 (0%) | 0% | 19.0 | 95,225 | Class A Common Stock |
| Enova Intl Inc | David A. Fisher | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 115.23 per share. | 14 Jul 2025 | 5,000 | 348,223 (1%) | 0% | 115.2 | 576,152 | Common stock, par value $0.00001 per share |
| Enova Intl Inc | David A. Fisher | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2025 | 5,000 | 165,562 | - | - | Non-Qualified Stock Option (right to buy) with limited SAR | |
| Enova Intl Inc | David A. Fisher | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.96 per share. | 14 Jul 2025 | 5,000 | 353,223 (1%) | 0% | 24.0 | 119,800 | Common stock, par value $0.00001 per share |
| Lemonade Inc | Timothy E. Bixby | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2025 | 5,000 | 284,300 | - | - | STOCK OPTION | |
| Lemonade Inc | Timothy E. Bixby | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 38.16 per share. | 14 Jul 2025 | 5,000 | 263,393 | - | 38.2 | 190,800 | COMMON STOCK |
| Lemonade Inc | Timothy E. Bixby | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.69 per share. | 14 Jul 2025 | 5,000 | 268,393 | - | 23.7 | 118,450 | COMMON STOCK |
| Incyte | Herve Hoppenot | Director, Special Advisor to the CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.98 per share. | 14 Jul 2025 | 4,961 | 521,859 (0%) | 0% | 70.0 | 347,171 | Common Stock |
| Chewy Inc (Class A) | James L. Nelson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 4,921 | 4,921 (0%) | 0% | 0 | Class A Common Stock | |
| Chewy Inc (Class A) | Martin H. Nesbitt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 4,921 | 4,921 (0%) | 0% | 0 | Class A Common Stock | |
| Chewy Inc (Class A) | Deborah G. Ellinger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 4,921 | 4,921 (0%) | 0% | 0 | Class A Common Stock | |
| Chewy Inc (Class A) | James A. Star | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 4,921 | 4,921 (0%) | 0% | 0 | Class A Common Stock | |
| Chewy Inc (Class A) | Kristine Dickson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 4,921 | 4,921 (0%) | 0% | 0 | Class A Common Stock | |
| Chewy Inc (Class A) | Nat Goldhaber | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 4,921 | 4,921 (0%) | 0% | 0 | Class A Common Stock | |
| Braze Inc (Class A) | Susan Wiseman | General Counsel | Sale of securities on an exchange or to another person at price $ 27.08 per share. | 14 Jul 2025 | 4,786 | 239,655 | - | 27.1 | 129,605 | Class A Common Stock |
| Qualys Inc | Sumedh S. Thakar | Director, CEO & PRESIDENT | Sale of securities on an exchange or to another person at price $ 138.81 per share. | 14 Jul 2025 | 4,774 | 216,288 (0%) | 0% | 138.8 | 662,673 | Common Stock |
| Incyte | Herve Hoppenot | Director, Special Advisor to the CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.25 per share. | 14 Jul 2025 | 4,713 | 517,146 (0%) | 0% | 68.2 | 321,662 | Common Stock |
| Johnson Controls | Christopher M. Scalia | EVP and CHRO | Grant, award, or other acquisition of securities at price $ 106.26 per share. | 14 Jul 2025 | 4,705 | 23,561 (0%) | 0% | 106.3 | 499,953 | Ordinary Shares |
| Monopar Therapeutics Inc | Kim R. Tsuchimoto | Director | 14 Jul 2025 | 4,704 | 0 | - | - | Stock Options | ||
| Aehr Test Systems | Gayn Erickson | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.86 per share. | 14 Jul 2025 | 4,518 | 272,511 (1%) | 0% | 13.9 | 62,619 | Common Stock |
| ReposiTrak | Randall K. Fields | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 18.62 per share. | 14 Jul 2025 | 4,500 | 139,500 (0%) | 0% | 18.6 | 83,771 | Common Stock |
| Incyte | Thomas Tray | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 4,482 | 24,313 (0%) | 0% | 0 | Common Stock | |
| Monopar Therapeutics Inc | Kim R. Tsuchimoto | Director | 14 Jul 2025 | 4,200 | 0 | - | - | Stock Options | ||
| Costco Wholesale | Yoram B. Rubanenko | Executive Vice President | Sale of securities on an exchange or to another person at price $ 974.96 per share. | 14 Jul 2025 | 4,000 | 5,774 (0%) | 0% | 975.0 | 3,899,852 | Common Stock |
| Theravance Biopharma Inc | Rhonda Farnum | SVP, COMM & MEDICAL AFFAIRS | Sale of securities on an exchange or to another person at price $ 11.39 per share. | 14 Jul 2025 | 4,000 | 326,918 (0%) | 0% | 11.4 | 45,552 | Ordinary Shares |
| Credo Tech Grp Holding Ltd | Chi Fung Cheng | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 100.00 per share. | 14 Jul 2025 | 3,942 | 7,273,961 | - | 100.0 | 394,196 | Ordinary Shares |
| Dolphin Entertainment Inc | William O’Dowd | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.28 per share. | 14 Jul 2025 | 3,900 | 247,979 (1%) | 0% | 1.3 | 4,984 | Common Stock |
| Atlassian Corp (Class A) | Michael Cannon-Brookes | Director, CEO, Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 192.24 per share. | 14 Jul 2025 | 3,800 | 424,190 (0%) | 0% | 192.2 | 730,494 | Class A Common Stock |
| Atlassian Corp (Class A) | Scott Farquhar | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 192.24 per share. | 14 Jul 2025 | 3,800 | 424,090 (0%) | 0% | 192.2 | 730,495 | Class A Common Stock |
| Incyte | Thomas Tray | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 3,362 | 3,362 | - | - | Employee Stock Option (right to buy) | |
| Central Pacific Fin Corp | Agnes Ngo | Director | Sale of securities on an exchange or to another person at price $ 29.20 per share. | 14 Jul 2025 | 3,333 | 68,792 (0%) | 0% | 29.2 | 97,324 | Common Stock |
| Dave Inc (Class A) | Kyle Beilman | CFO and COO and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 3,240 | 227,622 | - | 0 | Class A Common Stock | |
| Okta Inc (Class A) | Jonathan James Addison | Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 92.21 per share. | 14 Jul 2025 | 3,164 | 19,067 (0%) | 0% | 92.2 | 291,748 | Class A Common Stock |
| Datadog Inc (Class A) | Alexis Le-Quoc | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 136.78 per share. | 14 Jul 2025 | 3,100 | 491,137 (0%) | 0% | 136.8 | 424,021 | Class A Common Stock |
| Perma-Fix Environmental Services Inc | Richard Grondin | EVP of Hanford & Int. Waste Op | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.32 per share. | 14 Jul 2025 | 3,094 | 30,686 (0%) | 0% | 11.3 | 35,024 | Common Stock |
| Netsol Tech Inc | Najeeb U. Ghauri | Director, CEO | Purchase of securities on an exchange or from another person at price $ 3.71 per share. | 14 Jul 2025 | 3,025 | 921,338 (7%) | 0% | 3.7 | 11,223 | Common Stock |
| Qualys Inc | Sumedh S. Thakar | Director, CEO & PRESIDENT | Sale of securities on an exchange or to another person at price $ 137.92 per share. | 14 Jul 2025 | 3,000 | 221,062 (0%) | 0% | 137.9 | 413,753 | Common Stock |
| Credo Tech Grp Holding Ltd | Chi Fung Cheng | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 96.03 per share. | 14 Jul 2025 | 2,910 | 7,323,861 | - | 96.0 | 279,458 | Ordinary Shares |
| Okta Inc (Class A) | Jonathan James Addison | Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 91.78 per share. | 14 Jul 2025 | 2,863 | 22,231 (0%) | 0% | 91.8 | 262,775 | Class A Common Stock |
| GCI Liberty Inc - Ordinary Shares - Series A | Brian J. Wendling | CAO & PFO | Other type of transaction at price $ 0.00 per share. | 14 Jul 2025 | 2,746 | 2,746 | - | 0 | Series C GCI Group Common Stock | |
| Liquidia Corp | Sarah Krepp | Chief Human Resource Officer | 14 Jul 2025 | 2,673 | 142,499 (0%) | 0% | 14.3 | 38,170 | Common Stock | |
| Incyte | Pablo J. Cagnoni | President, R&D | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.25 per share. | 14 Jul 2025 | 2,628 | 217,262 (0%) | 0% | 68.3 | 179,361 | Common Stock |
| LMP Cap and Income Fund Inc | Peter Daniel Charles Mason | Director | Purchase of securities on an exchange or from another person at price $ 15.59 per share. | 14 Jul 2025 | 2,580 | 2,580 (0%) | 0% | 15.6 | 40,221 | Common Stock |
| Hims & Hers Health Inc (Class A) | Soleil Boughton | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 47.82 per share. | 14 Jul 2025 | 2,572 | 158,165 | - | 47.8 | 122,993 | Class A Common Stock |
| CalciMedica Inc | A. Rachel Leheny | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.47 per share. | 14 Jul 2025 | 2,500 | 2,500 | - | 2.5 | 6,175 | Common Stock |
| Pitney Bowes Inc | Lauren Thomas DeFina | VP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 12.00 per share. | 14 Jul 2025 | 2,500 | 5,121 (0%) | 0% | 12 | 30,000 | Common Stock |
| Pitney Bowes Inc | Lauren Thomas DeFina | VP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 12.50 per share. | 14 Jul 2025 | 2,500 | 2,621 (0%) | 0% | 12.5 | 31,250 | Common Stock |
| Okta Inc (Class A) | Jonathan James Addison | Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 91.70 per share. | 14 Jul 2025 | 2,500 | 16,567 (0%) | 0% | 91.7 | 229,240 | Class A Common Stock |
| TruGolf Inc (Class A) | Humphrey P. Polanen | Director | Sale of securities on an exchange or to another person at price $ 5.03 per share. | 14 Jul 2025 | 2,500 | 500 | - | 5.0 | 12,583 | Common Stock |
| Guidewire Software Inc | James Winston King | Chief Admin Officer, Gen Couns | Sale of securities on an exchange or to another person at price $ 220.65 per share. | 14 Jul 2025 | 2,482 | 37,441 (0%) | 0% | 220.6 | 547,653 | Common Stock |
| Intellicheck Inc | David E. Ullman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 2,381 | 2,381 | - | - | Restricted Stock Units (RSUs) | |
| Intellicheck Inc | Dylan Glenn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 2,381 | 2,381 | - | - | Restricted Stock Units (RSUs) | |
| Rogers Corp | Jeff Tsao | President of AES * | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 2,304 | 9,061 (0%) | 0% | 0 | Capital (Common) Stock | |
| Atlassian Corp (Class A) | Michael Cannon-Brookes | Director, CEO, Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 191.50 per share. | 14 Jul 2025 | 2,265 | 421,925 (0%) | 0% | 191.5 | 433,752 | Class A Common Stock |
| Atlassian Corp (Class A) | Scott Farquhar | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 191.50 per share. | 14 Jul 2025 | 2,265 | 421,825 (0%) | 0% | 191.5 | 433,752 | Class A Common Stock |
| Salesforce | Marc Benioff | Director, Chair and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 161.50 per share. | 14 Jul 2025 | 2,250 | 11,957,816 (1%) | 0% | 161.5 | 363,375 | Common Stock |
| Salesforce | Marc Benioff | Director, Chair and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2025 | 2,250 | 175,622 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Krystal Biotech Inc | Krish S. Krishnan | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 150.68 per share. | 14 Jul 2025 | 2,236 | 1,441,040 (8%) | 0% | 150.7 | 336,929 | Common Stock |
| Krystal Biotech Inc | Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 150.68 per share. | 14 Jul 2025 | 2,236 | 1,441,040 (8%) | 0% | 150.7 | 336,929 | Common Stock |
| Credo Tech Grp Holding Ltd | Chi Fung Cheng | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 95.24 per share. | 14 Jul 2025 | 2,190 | 7,326,771 | - | 95.2 | 208,567 | Ordinary Shares |
| Krystal Biotech Inc | Krish S. Krishnan | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 150.68 per share. | 14 Jul 2025 | 2,184 | 1,510,345 (8%) | 0% | 150.7 | 329,089 | Common Stock |
| Krystal Biotech Inc | Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 150.68 per share. | 14 Jul 2025 | 2,184 | 1,510,345 (8%) | 0% | 150.7 | 329,089 | Common Stock |
| Shimmick Corp | Mitchell B. Goldsteen | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.02 per share. | 14 Jul 2025 | 2,100 | 21,322,480 | - | 2.0 | 4,242 | Common Stock, par value $0.01 per share |
| Perma-Fix Environmental Services Inc | Richard Grondin | EVP of Hanford & Int. Waste Op | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.32 per share. | 14 Jul 2025 | 2,094 | 34,592 (0%) | 0% | 11.3 | 23,704 | Common Stock |
| FactSet Research | James J. Mcgonigle | Director | 14 Jul 2025 | 2,010 | 6,471 (0%) | 0% | 271.5 | 545,735 | Common Stock | |
| FactSet Research | James J. Mcgonigle | Director | 14 Jul 2025 | 2,010 | 0 | - | - | Non-Employee Director Stock Option (right to buy) | ||
| Netsol Tech Inc | Najeeb U. Ghauri | Director, CEO | Purchase of securities on an exchange or from another person at price $ 3.66 per share. | 14 Jul 2025 | 2,000 | 923,338 (7%) | 0% | 3.7 | 7,320 | Common Stock |
| Virco Manufacturing Corp | Robert A. Virtue | Director, CEO | Purchase of securities on an exchange or from another person at price $ 8.15 per share. | 14 Jul 2025 | 2,000 | 488,324 (3%) | 0% | 8.2 | 16,300 | Common Stock $.01 par value |
| EverQuote Inc (Class A) | John Shields | Director | Sale of securities on an exchange or to another person at price $ 24.30 per share. | 14 Jul 2025 | 2,000 | 31,219 (0%) | 0% | 24.3 | 48,600 | Class A Common Stock |
| Oxbridge Re Holdings Ltd | Allan Martin | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.45 per share. | 14 Jul 2025 | 2,000 | 237,131 (4%) | 0% | 2.4 | 4,896 | Ordinary Shares |
| Honeywell | James Masso | Pres & CEO, Process Solutions | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 1,901 | 1,901 | - | - | Restricted Stock Units | |
| Datadog Inc (Class A) | Alexis Le-Quoc | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 137.81 per share. | 14 Jul 2025 | 1,900 | 489,237 (0%) | 0% | 137.8 | 261,834 | Class A Common Stock |
| GCI Liberty Inc - Ordinary Shares - Series A | Renee L. Wilm | Chief Legal/Admin Officer | Other type of transaction at price $ 0.00 per share. | 14 Jul 2025 | 1,813 | 1,813 | - | 0 | Series C GCI Group Common Stock | |
| Microstrategy Inc (Class A) | W. Ming Shao | EVP & General Counsel | Sale of securities on an exchange or to another person at price $ 448.54 per share. | 14 Jul 2025 | 1,778 | 17,666 (0%) | 0% | 448.5 | 797,508 | Class A Common Stock |
| Moelis & Co (Class A) | Thorold Barker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 1,601 | 1,601 | - | - | 2025 Annual Restricted Stock Units | |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.25 per share. | 14 Jul 2025 | 1,596 | 94,315 (0%) | 0% | 68.3 | 108,927 | Common Stock |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.98 per share. | 14 Jul 2025 | 1,555 | 95,911 (0%) | 0% | 70.0 | 108,819 | Common Stock |
| Krystal Biotech Inc | Krish S. Krishnan | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 150.00 per share. | 14 Jul 2025 | 1,529 | 1,438,711 (8%) | 0% | 150 | 229,350 | Common Stock |
| Krystal Biotech Inc | Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 150.00 per share. | 14 Jul 2025 | 1,529 | 1,438,711 (8%) | 0% | 150 | 229,350 | Common Stock |
| ReposiTrak | Randall K. Fields | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 18.94 per share. | 14 Jul 2025 | 1,500 | 145,500 (0%) | 0% | 18.9 | 28,415 | Common Stock |
| ReposiTrak | Randall K. Fields | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 18.66 per share. | 14 Jul 2025 | 1,500 | 144,000 (0%) | 0% | 18.7 | 27,996 | Common Stock |
| GCI Liberty Inc - Ordinary Shares - Series A | Ronald A. Duncan | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 14 Jul 2025 | 1,461 | 1,461 | - | 0 | Series C GCI Group Common Stock | |
| GCI Liberty Inc - Ordinary Shares - Series A | Richard R. Green | Director | Other type of transaction at price $ 0.00 per share. | 14 Jul 2025 | 1,460 | 1,460 | - | 0 | Series C GCI Group Common Stock | |
| Incyte | Christiana Stamoulis | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.25 per share. | 14 Jul 2025 | 1,445 | 114,652 (0%) | 0% | 68.2 | 98,621 | Common Stock |
| FactSet Research | James J. Mcgonigle | Director | 14 Jul 2025 | 1,425 | 4,461 (0%) | 0% | 452.0 | 644,072 | Common Stock | |
| Incyte | Christiana Stamoulis | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.98 per share. | 14 Jul 2025 | 1,407 | 116,097 (0%) | 0% | 70.0 | 98,462 | Common Stock |
| Guidewire Software Inc | Michael Rosenbaum | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 220.65 per share. | 14 Jul 2025 | 1,400 | 233,068 (0%) | 0% | 220.7 | 308,910 | Common Stock |
| Krystal Biotech Inc | Krish S. Krishnan | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 150.00 per share. | 14 Jul 2025 | 1,389 | 1,508,056 (8%) | 0% | 150 | 208,350 | Common Stock |
| Krystal Biotech Inc | Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 150.00 per share. | 14 Jul 2025 | 1,389 | 1,508,056 (8%) | 0% | 150 | 208,350 | Common Stock |
| Shimmick Corp | Mitchell B. Goldsteen | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 1.99 per share. | 14 Jul 2025 | 1,300 | 21,331,580 | - | 2.0 | 2,587 | Common Stock, par value $0.01 per share |
| Blackstone | James W. Breyer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 1,295 | 41,836 (0%) | 0% | 0 | Common Stock | |
| Carvana Co. (Class A) | Ernest Garcia | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 348.63 per share. | 14 Jul 2025 | 1,284 | 757,316 (1%) | 0% | 348.6 | 447,641 | Class A Common Stock |
| Carvana Co. (Class A) | Ernest Garcia | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 348.63 per share. | 14 Jul 2025 | 1,284 | 657,316 (1%) | 0% | 348.6 | 447,641 | Class A Common Stock |
| Incyte | Pablo J. Cagnoni | President, R&D | Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.98 per share. | 14 Jul 2025 | 1,280 | 219,890 (0%) | 0% | 70.0 | 89,574 | Common Stock |
| Atlassian Corp (Class A) | Michael Cannon-Brookes | Director, CEO, Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 193.18 per share. | 14 Jul 2025 | 1,250 | 427,990 (0%) | 0% | 193.2 | 241,479 | Class A Common Stock |
| Atlassian Corp (Class A) | Scott Farquhar | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 193.18 per share. | 14 Jul 2025 | 1,250 | 427,890 (0%) | 0% | 193.2 | 241,479 | Class A Common Stock |
| Ventas | Debra A. Cafaro | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2025 | 1,224 | 706,306 | - | - | Stock Option (Right to Buy) | |
| Ventas | Debra A. Cafaro | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 65.62 per share. | 14 Jul 2025 | 1,224 | 1,145,695 (0%) | 0% | 65.6 | 80,320 | Common Stock |
| Ventas | Debra A. Cafaro | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 65.45 per share. | 14 Jul 2025 | 1,224 | 1,146,919 (0%) | 0% | 65.5 | 80,111 | Common Stock |
| Beyond Meat Inc | Lubi Kutua | CFO, Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.46 per share. | 14 Jul 2025 | 1,205 | 177,783 (0%) | 0% | 3.5 | 4,169 | Common Stock |
| FactSet Research | James J. Mcgonigle | Director | 14 Jul 2025 | 1,200 | 5,886 (0%) | 0% | 451.1 | 541,260 | Common Stock | |
| Liquidia Corp | Dana Boyle | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 14.28 per share. | 14 Jul 2025 | 1,193 | 187,168 (0%) | 0% | 14.3 | 17,036 | Common Stock |
| Incyte | Barry P. Flannelly | EVP & General Manager US | Sale of securities on an exchange or to another person at price $ 69.86 per share. | 14 Jul 2025 | 1,192 | 37,630 (0%) | 0% | 69.9 | 83,273 | Common Stock |
| Incyte | Vijay K. Iyengar | EVP, GMAPPS | Sale of securities on an exchange or to another person at price $ 69.86 per share. | 14 Jul 2025 | 1,177 | 35,929 (0%) | 0% | 69.9 | 82,225 | Common Stock |
| Levi Strauss & Co. - Ordinary Shares Cls A | Bradley J. Haas | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 21.32 per share. | 14 Jul 2025 | 1,150 | 0 (0%) | 0% | 21.3 | 24,518 | Class A Common Stock |
| Incyte | Barry P. Flannelly | EVP & General Manager US | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.25 per share. | 14 Jul 2025 | 1,141 | 36,489 (0%) | 0% | 68.2 | 77,873 | Common Stock |
| Essential Properties Realty Trust Inc | Peter M. Mavoides | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 1,139 | 419,406 (0%) | 0% | 0 | Common Stock | |
| Annexon Inc | Jennifer Lew | EVP & CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 2.58 per share. | 14 Jul 2025 | 1,117 | 121,616 | - | 2.6 | 2,882 | Common Stock |
| Annexon Inc | Ted Yednock | EVP & CHIEF INNOVATION OFFICER | Sale of securities on an exchange or to another person at price $ 2.58 per share. | 14 Jul 2025 | 1,116 | 105,084 | - | 2.6 | 2,879 | Common Stock |
| Microstrategy Inc (Class A) | W. Ming Shao | EVP & General Counsel | Sale of securities on an exchange or to another person at price $ 455.14 per share. | 14 Jul 2025 | 1,104 | 12,726 (0%) | 0% | 455.1 | 502,473 | Class A Common Stock |
| Carvana Co. (Class A) | Ernest Garcia | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 347.62 per share. | 14 Jul 2025 | 1,075 | 758,600 (1%) | 0% | 347.6 | 373,692 | Class A Common Stock |
| Carvana Co. (Class A) | Ernest Garcia | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 347.17 per share. | 14 Jul 2025 | 1,074 | 658,600 (1%) | 0% | 347.2 | 372,861 | Class A Common Stock |
| Microstrategy Inc (Class A) | W. Ming Shao | EVP & General Counsel | Sale of securities on an exchange or to another person at price $ 450.61 per share. | 14 Jul 2025 | 1,074 | 15,641 (0%) | 0% | 450.6 | 483,954 | Class A Common Stock |
| Ally Fin Inc | Thomas P. Gibbons | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 1,072 | 17,924 (0%) | 0% | 0 | Common Stock | |
| Aehr Test Systems | Vernon Rogers | Exec VP of Sales & Mktg. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.86 per share. | 14 Jul 2025 | 1,058 | 68,578 (0%) | 0% | 13.9 | 14,664 | Common Stock |
| Microstrategy Inc (Class A) | W. Ming Shao | EVP & General Counsel | Sale of securities on an exchange or to another person at price $ 451.37 per share. | 14 Jul 2025 | 1,022 | 14,619 (0%) | 0% | 451.4 | 461,304 | Class A Common Stock |
| Carvana Co. (Class A) | Ernest Garcia | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 346.17 per share. | 14 Jul 2025 | 1,016 | 659,674 (1%) | 0% | 346.2 | 351,709 | Class A Common Stock |
| Microstrategy Inc (Class A) | W. Ming Shao | EVP & General Counsel | Sale of securities on an exchange or to another person at price $ 447.59 per share. | 14 Jul 2025 | 1,016 | 19,444 (0%) | 0% | 447.6 | 454,749 | Class A Common Stock |
| Carvana Co. (Class A) | Ernest Garcia | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 346.64 per share. | 14 Jul 2025 | 1,015 | 759,675 (1%) | 0% | 346.6 | 351,840 | Class A Common Stock |
| Grindr Inc (Class A) | Nathan A. Richardson | Director | Sale of securities on an exchange or to another person at price $ 21.26 per share. | 14 Jul 2025 | 1,000 | 14,126 | - | 21.3 | 21,260 | Common Stock |
| Intellicheck Inc | Dondi Black | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 952 | 952 | - | - | Restricted Stock Units (RSUs) | |
| Microstrategy Inc (Class A) | W. Ming Shao | EVP & General Counsel | Sale of securities on an exchange or to another person at price $ 449.37 per share. | 14 Jul 2025 | 951 | 16,715 (0%) | 0% | 449.4 | 427,351 | Class A Common Stock |
| Salesforce | Marc Benioff | Director, Chair and CEO | Sale of securities on an exchange or to another person at price $ 260.19 per share. | 14 Jul 2025 | 922 | 11,956,442 (1%) | 0% | 260.2 | 239,898 | Common Stock |
| Incyte | Barry P. Flannelly | EVP & General Manager US | Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.98 per share. | 14 Jul 2025 | 922 | 38,822 (0%) | 0% | 70.0 | 64,522 | Common Stock |
| FactSet Research | James J. Mcgonigle | Director | 14 Jul 2025 | 915 | 7,386 (0%) | 0% | 318.2 | 291,153 | Common Stock | |
| FactSet Research | James J. Mcgonigle | Director | 14 Jul 2025 | 915 | 0 | - | - | Non-Employee Director Stock Option (right to buy) | ||
| Krystal Biotech Inc | Krish S. Krishnan | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 151.79 per share. | 14 Jul 2025 | 900 | 1,509,445 (8%) | 0% | 151.8 | 136,611 | Common Stock |
| Krystal Biotech Inc | Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 151.79 per share. | 14 Jul 2025 | 900 | 1,509,445 (8%) | 0% | 151.8 | 136,611 | Common Stock |
| Salesforce | Marc Benioff | Director, Chair and CEO | Sale of securities on an exchange or to another person at price $ 260.96 per share. | 14 Jul 2025 | 876 | 11,955,566 (1%) | 0% | 261.0 | 228,598 | Common Stock |
| Microstrategy Inc (Class A) | W. Ming Shao | EVP & General Counsel | Sale of securities on an exchange or to another person at price $ 445.74 per share. | 14 Jul 2025 | 856 | 21,264 (0%) | 0% | 445.7 | 381,553 | Class A Common Stock |
| Annexon Inc | Michael Overdorf | EVP & CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 2.61 per share. | 14 Jul 2025 | 853 | 130,689 | - | 2.6 | 2,226 | Common Stock |
| GCI Liberty Inc - Ordinary Shares - Series A | Ronald A. Duncan | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 14 Jul 2025 | 839 | 839 | - | 0 | Series C GCI Group Common Stock | |
| Incyte | Vijay K. Iyengar | EVP, GMAPPS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.25 per share. | 14 Jul 2025 | 836 | 35,093 (0%) | 0% | 68.3 | 57,057 | Common Stock |
| Ally Fin Inc | David Reilly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 835 | 30,053 (0%) | 0% | 0 | Common Stock | |
| Aehr Test Systems | Donald P. Richmond | CTO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.86 per share. | 14 Jul 2025 | 811 | 214,694 (0%) | 0% | 13.9 | 11,240 | Common Stock |
| Microstrategy Inc (Class A) | W. Ming Shao | EVP & General Counsel | Sale of securities on an exchange or to another person at price $ 446.47 per share. | 14 Jul 2025 | 804 | 20,460 (0%) | 0% | 446.5 | 358,962 | Class A Common Stock |
| Broadcom | Justine Lien | Director | Sale of securities on an exchange or to another person at price $ 274.30 per share. | 14 Jul 2025 | 800 | 24,582 (0%) | 0% | 274.3 | 219,440 | Common Stock, $0.001 par value |
| Krystal Biotech Inc | Krish S. Krishnan | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 151.79 per share. | 14 Jul 2025 | 800 | 1,440,240 (8%) | 0% | 151.8 | 121,432 | Common Stock |
| Krystal Biotech Inc | Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 151.79 per share. | 14 Jul 2025 | 800 | 1,440,240 (8%) | 0% | 151.8 | 121,432 | Common Stock |
| Katapult Holdings Inc | Jane J. Thompson | Director | 14 Jul 2025 | 800 | 44,535 | - | 10.3 | 8,248 | Common Stock | |
| Toll Brothers Inc | Christine N. Garvey | Director | 14 Jul 2025 | 770 | 11,590 (0%) | 0% | 119.8 | 92,258 | Common Stock |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.